Results 241 to 250 of about 655,147 (306)

Effects of the Factor Xa Inhibitor, Fondaparinux, on the Stability of Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice

, 2015
Pengfei Zuo, Qianxing Zhou, Zhi Zuo, Xin Wang, Long Chen, Genshan Ma   +5 more
openalex   +2 more sources

Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors

, 2001
Ting Su, Yanhong Wu, Brandon Doughan, Zhaozhong J. Jia, John Woolfrey, Brian Huang, Paul Wong, Gary Park, Uma Sinha, Robert M. Scarborough, Bing‐Yan Zhu   +10 more
openalex   +1 more source

Factor Xa inhibitors versus warfarin in patients with non-valvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Zahoor MM, Mazhar S, Azhar A, Mand Khan F, Anees U, Vohra RR, Ejaz U, Jawad S.   +7 more
europepmc   +1 more source

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. [PDF]

Clin Pharmacokinet
Rohr BS, Krohmer E, Foerster KI, Burhenne J, Schulz M, Blank A, Mikus G, Haefeli WE.   +7 more
europepmc   +1 more source

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. [PDF]

Eur Stroke J
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C.   +14 more
europepmc   +1 more source

Low-molecular-weight heparin is associated with lower venous thromboembolism events than factor Xa inhibitors in patients with severe blunt trauma: a cohort study from the Trauma Quality Improvement Program. [PDF]

Int J Surg
Chan SY, Huang JF, Cheng CT, Hsu CP, Liao CH, Fu CY.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis

The Annals of Pharmacotherapy, 2020
Background: Clinical practice guidelines recommend that cerebral venous thrombosis (CVT) be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight heparin (LMWH) for 3 to 12 months.
Marissa Z Powell, Kathryn Tremolet de Villers, K. Schwarz, D. Case, T. Trujillo   +4 more
semanticscholar   +1 more source

Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?

HIP International, 2020
Introduction: Debate over the ideal agent for venous thromboembolism (VTE) prophylaxis after total hip arthroplasty (THA) has led to changes in prescribing trends of commonly used agents. We investigate variation in utilisation and the differences in VTE
Abiram Bala, M. Murasko, D. Burk, J. Huddleston, S. Goodman, W. Maloney, D. Amanatullah   +6 more
semanticscholar   +1 more source